58-37f-702. Reporting prescribed controlled substance poisoning or overdose to a practitioner.

402 words·~2 min read·/ut/title-58/chapter-37f/58-37f-702

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Effective 7/1/2026

(a)The division shall take the actions described in Subsection (1)(b) if the division receives a report from a general acute hospital under Section 26B-2-225 regarding admission to a general acute hospital for poisoning or overdose involving a prescribed controlled substance.

(b)The division shall, within five business days after the day on which a report in Subsection (1)(a) is received:

(i)attempt to identify, through the database, each practitioner who may have prescribed the controlled substance to the patient; and

(ii)alert each practitioner identified under Subsection (1)(b)(i) concerning the information described in this Subsection

(1).

(a)When the division receives a report from the medical examiner under Section 26B-8-210 regarding a death caused by poisoning or overdose involving a prescribed controlled substance, for each practitioner the medical examiner identifies under Subsection 26B-8-210(1)(c) , the division:

(i)shall, within five business days after the day on which the division receives the report, provide the practitioner with a copy of the report; and

(ii)may offer the practitioner an educational visit to review the report.

(b)A practitioner may decline an educational visit described in Subsection (2)(a)(ii) .

(c)The division may not use, in a licensing investigation or action by the division:

(i)information from an educational visit described in Subsection (2)(a)(ii) ; or

(ii)a practitioner's decision to decline an educational visit described in Subsection (2)(a)(ii) .

(3)It is the intent of the Legislature that the information provided under Subsection

(1)or

(2)is provided for the purpose of assisting the practitioner in:

(a)discussing with the patient or others issues relating to the poisoning or overdose;

(b)advising the patient or others of measures that may be taken to avoid a future poisoning or overdose; and

(c)making decisions regarding future prescriptions written for the patient or others.

(4)Any record the division creates as a result of an educational visit described in Subsection (2)(a)(ii) is a protected record for purposes of Title 63G, Chapter 2, Government Records Access and Management Act .

(5)Beginning on July 1, 2010, the division shall, in accordance with Section 63J-1-504 , increase the licensing fee described in Subsection 58-37-105(1)(b) to pay the startup and ongoing costs of the division for complying with the requirements of this section.

Amended by Chapter 64 , 2026 General Session